Clinical Trials · NCT07718126
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
- Phase
- Phase 2/Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- West China Hospital
- Enrollment
- 60
- Start date
- Sep 2026
- Locations
- 3 sites, China
- Primary endpoint
- Proportion of Participants Achieving Resolution of MASLD Without Worsening of Liver Fibrosis (ROM)